Faulkingham Dell 4
4 · Akebia Therapeutics, Inc. · Filed Mar 18, 2021
Insider Transaction Report
Form 4
Transactions
- Award
Common Stock
2021-03-16+9,152→ 137,977 total
Footnotes (1)
- [F1]As previously disclosed, in February 2020, the Reporting Person was granted performance-based restricted stock unit awards ("PSUs") pursuant to the Issuer's 2014 Incentive Plan, as amended. The PSUs vest in connection with the achievement of specified commercial and regulatory milestones. On February 25, 2021, the Company reported its financial results for the year ended December 31, 2020. Subsequently, in accordance with the terms of the grant, the Issuer's Compensation Committee certified the achievement of a commercial milestone and, as a result, one third of the reported PSUs will vest on each of March 31, 2021, February 28, 2022 and February 28, 2023, subject to the Reporting Person's continued service with the Issuer on each vesting date.